Cove Private Wealth’s Gilead Sciences GILD Stock Holding History

Cove Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	14,803 +663	+5%	+$87.4K	0.36%	51
2026 Q1	$1.97M	Hold	14,140	–	–	0.45%	43
2025 Q4	$1.74M	Hold	14,140	–	–	0.52%	46
2025 Q3	$1.57M	Hold	14,140	–	–	0.5%	47
2025 Q2	$1.57M	Buy	14,140 +290	+2%	+$30.9K	0.55%	45
2025 Q1	$1.55M	Hold	13,850	–	–	0.82%	34
2024 Q4	$1.28M	Hold	13,850	–	–	0.77%	36
2024 Q3	$1.16M	Hold	13,850	–	–	0.9%	33
2024 Q2	$950K	Hold	13,850	–	–	0.76%	39
2024 Q1	$1.01M	Hold	13,850	–	–	0.87%	35
2023 Q4	$1.12M	Buy	+13,850	New	+$1.08M	1.06%	32

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cove Private Wealth's GILD Position: Q2 2026 in Review

Cove Private Wealth increased its Gilead Sciences (GILD) stake by 4.7% in Q2 2026, buying an estimated $87.4K and bringing the position to 14,803 shares worth $1.87M. The position accounts for 0.36% of the portfolio, ranked #51.

Cove Private Wealth first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.97M in Q1 2026. 1,006 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Cove Private Wealth held 14,803 shares of Gilead Sciences worth $1.87M as of Q2 2026.
Cove Private Wealth bought 663 Gilead Sciences shares in Q2 2026, an estimated $87.4K.
Gilead Sciences made up 0.36% of Cove Private Wealth's portfolio in Q2 2026, its #51 holding.
Cove Private Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Cove Private Wealth's Gilead Sciences position peaked at $1.97M in Q1 2026.
1,006 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.